Pharmaceutical

Prolific biotechnology investment firm Atlas Venture said Thursday it raised $400 million to pump into its existing portfolio of drug startups, a move...

U.S. lawmakers clashed with Health and Human Services Secretary Robert F. Kennedy Jr. over his changes to the country’s vaccine policy and oversight o...

Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain

Survey reveals lack of awareness need for greater clarity Survey reveals lack of awareness need for greater clarity

A new campaign from Aflac aims to be more than just a one-off awareness push. Instead, the supplemental health insurance company is hoping it’ll becom...

BD is putting a fresh spin on an old awareness drive, returning to the 12-year-old “Love Your Limbs” campaign to mark Peripheral Artery Disease (PAD)...

Amid ongoing upheaval at the FDA and other federal health agencies, prominent vaccine expert and Robert F. Kennedy Jr. critic Paul Offit, M.D., has be...

The U.K. is losing business opportunities in the life sciences sector because the government undervalues the economic and social benefits of investing...

AstraZeneca is advancing plans to exit production in India by giving up its manufacturing license in the country some two years before it was set to e...

The pharmaceutical lobby is ramping up its opposition to nonprofit health systems’ expanding use of the 340B Drug Discount program with the launch of...